학술논문

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
Document Type
Article
Source
In: The Lancet Gastroenterology and Hepatology. (The Lancet Gastroenterology and Hepatology, April 2022, 7(4):294-306)
Subject
Language
English
ISSN
24681253